{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:56:07Z","timestamp":1790646967591,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Research Foundation funded by the Ministry of Education of Korea","award":["NRF-2018R1D1A1B07043681"],"award-info":[{"award-number":["NRF-2018R1D1A1B07043681"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00296-019-04447-w","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T06:02:31Z","timestamp":1569304951000},"page":"1919-1926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2010-4440","authenticated-orcid":false,"given":"Sun Moon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8496-5613","authenticated-orcid":false,"given":"Song-Yi","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5459-9635","authenticated-orcid":false,"given":"Seon Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5235-2612","authenticated-orcid":false,"given":"Jinhyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"4447_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311","journal-title":"Arthritis Rheum"},{"key":"4447_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/art.20077","volume":"51","author":"A Mahr","year":"2004","unstructured":"Mahr A, Guillevin L, Poissonnet M, Ayme S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51:92\u201399","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 1","key":"4447_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/ndt\/gfv022","volume":"30","author":"RA Watts","year":"2015","unstructured":"Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Su\u00e1rez LF (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transpl 30(Suppl. 1):14\u201322","journal-title":"Nephrol Dial Transpl"},{"key":"4447_CR4","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","volume":"26","author":"M Groh","year":"2015","unstructured":"Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K et al (2015) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) consensus task force recommendations for evaluation and management. Eur J Intern Med 26:545\u2013553","journal-title":"Eur J Intern Med"},{"key":"4447_CR5","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM198806233182504","volume":"318","author":"RJ Falk","year":"1998","unstructured":"Falk RJ, Jennette JC (1998) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318:1651\u20131657","journal-title":"N Engl J Med"},{"key":"4447_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1084\/jem.171.1.357","volume":"171","author":"J Ludemann","year":"1990","unstructured":"Ludemann J, Utecht B, Gross WL (1990) Anti-neutrophil cytoplasm antibodies in Wegener\u2019s granulomatosis recognize an elastinolytic enzyme. J Exp Med 171:357\u2013362","journal-title":"J Exp Med"},{"key":"4447_CR7","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/346520a0","volume":"346","author":"DE Jenne","year":"1990","unstructured":"Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL (1990) Wegener\u2019s autoantigen decoded. Nature 346:520","journal-title":"Nature"},{"key":"4447_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","volume":"12","author":"D Cornec","year":"2016","unstructured":"Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U (2016) ANCA-associated vasculitis\u2014clinical utility of using ANCA specificity to classify patients. Nature Rev Rheumatol 12:570\u2013579","journal-title":"Nature Rev Rheumatol"},{"key":"4447_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","volume":"53","author":"EC Hagen","year":"1998","unstructured":"Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, Lesavre P et al (1998) Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC\/BCR project for ANCA assay standardization. Kidney Int 53:743\u2013753","journal-title":"Kidney Int"},{"key":"4447_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s10067-015-3086-8","volume":"35","author":"S Shah","year":"2016","unstructured":"Shah S, Havill J, Rahman MH, Geetha D (2016) A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis. Clin Rheumatol 35:953\u2013960","journal-title":"Clin Rheumatol"},{"key":"4447_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2796.1998.00357.x","volume":"244","author":"C Franssen","year":"1998","unstructured":"Franssen C, Gans R, Kallenberg C, Hageluken C, Hoorntje S (1998) Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J Intern Med 244:209\u2013216","journal-title":"J Intern Med"},{"key":"4447_CR12","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/rheumatology\/kex293","volume":"56","author":"FA Pearce","year":"2017","unstructured":"Pearce FA, Craven A, Merkel PA, Luqmani RA, Watts RA (2017) Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 56:1962\u20131969","journal-title":"Rheumatology (Oxford)"},{"key":"4447_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4172\/2155-9899.1000335","volume":"6","author":"J Chou","year":"2015","unstructured":"Chou J, Randall K, Gatenby P (2015) Clinical outcomes of patients with dual positivity for proteinase 3 and myeloperoxidase specific antineutrophil cytoplasmic antibodies. J Clin Cell Immunol 6:3. \nhttps:\/\/doi.org\/10.4172\/2155-9899.1000335","journal-title":"J Clin Cell Immunol"},{"key":"4447_CR14","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S (2009) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68:1827\u20131832","journal-title":"Ann Rheum Dis"},{"key":"4447_CR15","doi-asserted-by":"publisher","first-page":"e015668","DOI":"10.1136\/bmjopen-2016-015668","volume":"7","author":"C Li","year":"2017","unstructured":"Li C, Zhou ML, Liang DD, Wang JJ, Yang J, Zeng CH et al (2017) Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study. BMJ Open 7:e015668","journal-title":"BMJ Open"},{"key":"4447_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/s10165-012-0619-8","volume":"23","author":"M Murakami","year":"2013","unstructured":"Murakami M, Shimane K, Takahashi H, Tomiyama J, Nagashima M (2013) ANCA-associated vasculitis with dual ANCA positivity in coexistence with mixed connective tissue disease. Mod Rheumatol 23:156\u2013161","journal-title":"Mod Rheumatol"},{"key":"4447_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s10157-005-0382-7","volume":"9","author":"H Ueda","year":"2005","unstructured":"Ueda H, Ishimura E, Yunoki T, Tsuchida T, Matsumoto N, Jono S et al (2005) Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA. Clin Exp Nephrol 9:332\u2013334","journal-title":"Clin Exp Nephrol"},{"key":"4447_CR18","first-page":"233","volume":"22","author":"I Ferraz-Amaro","year":"2004","unstructured":"Ferraz-Amaro I, Herrero MJ, Jurado A, Diaz-Gonzalez F (2004) Dual positivity for cytoplasmic and perinuclear anti-neutrophil antibodies in a patient with Henoch-Schonlein purpura. Clin Exp Rheumatol 22:233\u2013234","journal-title":"Clin Exp Rheumatol"},{"key":"4447_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/RHU.0b013e318164187a","volume":"14","author":"AM Tiliakos","year":"2008","unstructured":"Tiliakos AM, Tiliakos NA (2008) Dual ANCA positivity in subacute bacterial endocarditis. J Clin Rheumatol 14:38\u201340","journal-title":"J Clin Rheumatol"},{"key":"4447_CR20","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2215\/CJN.01020113","volume":"8","author":"AA de Joode","year":"2013","unstructured":"de Joode AA, Sanders JS, Stegeman CA (2013) Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol 8:1709\u20131717","journal-title":"Clin J Am Soc Nephrol"},{"key":"4447_CR21","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3899\/jrheum.131038","volume":"41","author":"AJ Mohammad","year":"2014","unstructured":"Mohammad AJ, Segelmark M (2014) A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis. J Rheumatol 41:1366\u20131373","journal-title":"J Rheumatol"},{"key":"4447_CR22","doi-asserted-by":"publisher","first-page":"R101","DOI":"10.1186\/ar4550","volume":"16","author":"KE Sada","year":"2014","unstructured":"Sada KE, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, Ito S et al (2014) Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 16:R101","journal-title":"Arthritis Res Ther"},{"key":"4447_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/MD.0000000000000217","volume":"93","author":"C Comarmond","year":"2014","unstructured":"Comarmond C, Crestani B, Tazi A, Hervier B, Adam-Marchand S, Nunes H, Cohen-Aubart F et al (2014) Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine (Baltimore) 93:340\u2013349","journal-title":"Medicine (Baltimore)"},{"key":"4447_CR24","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","volume":"75","author":"S Unizony","year":"2016","unstructured":"Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, Seo P et al (2016) Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis 75:1166\u20131169","journal-title":"Ann Rheum Dis"},{"key":"4447_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12890-015-0068-1","volume":"15","author":"S Ikeda","year":"2015","unstructured":"Ikeda S, Arita M, Misaki K, Kashiwagi Y, Ito Y, Yamada H et al (2015) Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study. BMC Pulm Med 15:78","journal-title":"BMC Pulm Med"},{"key":"4447_CR26","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"RJ Falk","year":"1990","unstructured":"Falk RJ, Terrell RS, Charles LA, Jennette JC (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87:4115\u20134119","journal-title":"Proc Natl Acad Sci USA"},{"key":"4447_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110:955\u2013963","journal-title":"J Clin Invest"},{"key":"4447_CR28","doi-asserted-by":"publisher","first-page":"8188","DOI":"10.1038\/srep08188","volume":"5","author":"C Glasner","year":"2015","unstructured":"Glasner C, van Timmeren MM, Stobernack T, Omansen TF, Raangs EC, Rossen JW, de Goffau MC et al (2015) Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure. Sci Rep 5:8188","journal-title":"Sci Rep"},{"key":"4447_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/ar410","volume":"4","author":"H Brockmann","year":"2002","unstructured":"Brockmann H, Schwarting A, Kriegsmann J, Petrow P, Gaumann A, M\u00fcller KM et al (2002) Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener\u2019s granulomatosis. Arthritis Res 4:220\u2013225","journal-title":"Arthritis Res"},{"key":"4447_CR30","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1046\/j.1523-1755.2000.00100.x","volume":"57","author":"A Schwarting","year":"2000","unstructured":"Schwarting A, Hagen D, Odenthal M, Brockmann H, Dienes HP, Wandel E et al (2000) Proteinase-3 mRNA expressed by glomerular epithelial cells correlates with crescent formation in Wegener\u2019s granulomatosis. Kidney Int 57:2412\u20132422","journal-title":"Kidney Int"},{"key":"4447_CR31","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/ki.2015.202","volume":"88","author":"KM O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan KM, Lo CY, Summers SA, Elgass KD, McMillan PJ, Longano A et al (2015) Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis. Kidney Int 88:1030\u20131046","journal-title":"Kidney Int"},{"key":"4447_CR32","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/art.39812","volume":"68","author":"EM Miloslavsky","year":"2016","unstructured":"Miloslavsky EM, Lu N, Unizony S, Choi HK, Merkel PA, Seo P et al (2016) Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)\u2013positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener\u2019s). Arthritis Rheumatol 68:2945\u20132952","journal-title":"Arthritis Rheumatol"},{"key":"4447_CR33","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/art.39786","volume":"68","author":"JH Schirmer","year":"2016","unstructured":"Schirmer JH, Wright M, Herrmann K, Laudien M, Nolle B, Reinhold-Keller E et al (2016) Myeloperoxidase\u2013antineutrophil cytoplasmic antibody (ANCA)\u2013positive granulomatosis with polyangiitis (Wegener\u2019s) is a clinically distinct subset of ANCA-associated vasculitis. Arthritis Rheumatol 68:2953\u20132956","journal-title":"Arthritis Rheumatol"},{"key":"4447_CR34","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/j.1523-1755.2005.00679.x","volume":"68","author":"M Chen","year":"2005","unstructured":"Chen M, Yu F, Zhang Y, Zou WZ, Zhao MH, Wang HY (2005) Characteristics of Chinese patients with Wegener\u2019s granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int 68:2225\u20132229","journal-title":"Kidney Int"},{"key":"4447_CR35","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00296-014-3106-z","volume":"35","author":"N Ono","year":"2015","unstructured":"Ono N, Niiro H, Ueda A, Sawabe T, Nishizaka H, Furugo I et al (2015) Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan. Rheumatol Int 35:555\u2013559","journal-title":"Rheumatol Int"},{"key":"4447_CR36","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1002\/art.34562","volume":"64","author":"S Lionaki","year":"2012","unstructured":"Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 64:3452\u20133462","journal-title":"Arthritis Rheum"},{"key":"4447_CR37","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310\u2013317","journal-title":"Ann Rheum Dis"},{"key":"4447_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75:1583\u20131594","journal-title":"Ann Rheum Dis"},{"key":"4447_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez148","author":"A Mahr","year":"2019","unstructured":"Mahr A, Specks U, Jayne D (2019) Subclassifying ANCA-Associated vasculitis: a unifying view of disease spectrum. Rheumatology. \nhttps:\/\/doi.org\/10.1093\/rheumatology\/kez148\n\n(Epub ahead of print)","journal-title":"Rheumatology"},{"key":"4447_CR40","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","volume":"72","author":"A Mahr","year":"2013","unstructured":"Mahr A, Katsahian S, Varet H, Guillevin L, Hagen EC, H\u00f6glund P et al (2013) Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis 72:1003\u20131010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4447_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11926-019-0835-8","volume":"21","author":"N Emejuaiwe","year":"2019","unstructured":"Emejuaiwe N (2019) Treatment strategies in ANCA-associated vasculitis. Curr Rheumatol Rep 21(7):33","journal-title":"Curr Rheumatol Rep"},{"key":"4447_CR42","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1002\/art.38044","volume":"65","author":"EM Miloslavsky","year":"2013","unstructured":"Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA et al (2013) Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 65:2441\u20132449","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04447-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04447-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04447-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T07:18:40Z","timestamp":1603178320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04447-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["4447"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04447-w","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,24]]},"assertion":[{"value":"13 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by Chungnam National University Hospital Institutional Review Board (2017-1-31\/2017-01-023) and Chungbuk National University Hospital Institutional Review Board (2019-4-25\/CBNUH 2017-04-001) and informed consent was waived by each ethics committees. This study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}